1. Eyeing Varun Beverages shares? Should you buy? find out

Eyeing Varun Beverages shares? Should you buy? find out

Weaker-than-expected 3QCY17 performance and GST-led disruption in 2Q led to a relatively muted 9MCY17 (broadly representative of CY2017 as 4Q is a seasonally weak quarter).

By: | Published: November 8, 2017 3:41 AM
EBITDA margin contracted 20 bps y-o-y to 19.2% as sharp GM contraction of 460 bps y-o-y (due to inflation in sugar prices and phasing of promotional spends by PepsiCo — this gets discounted from VBL’s concentrate pricing) was negated by a similar quantum of savings in other expenditure (led by GST-led savings and lower logistics costs due to realignment of operations).

Weaker-than-expected 3QCY17 performance and GST-led disruption in 2Q led to a relatively muted 9MCY17 (broadly representative of CY2017 as 4Q is a seasonally weak quarter). Low base, a robust NPD pipeline, recent acquisition of Odisha/MP territories and macro pickup is likely to drive stronger growth in CY2018; our estimates remain broadly unchanged. Retain ‘buy’ and revise TP to Rs 600/share as we roll-over to September 2019. We note VBL’s reported financials (under Ind-AS) aren’t strictly comparable to our quarterly/full- year estimates (under IGAAP) below EBITDA-line; the company didn’t share comparable IGAAP financials this time. That said, consolidated earning print for 3QCY17 was a tad weaker-than-expected – net revenues grew 7 % y-o-y to Rs 9.63 billion (5% below estimates), EBITDA grew 6% y-o-y to Rs 1.85 billion and recurring PAT grew 219 % y-o-y to Rs 329 million. Revenue growth was aided by 5.4% volume growth led by 4% volume growth in India business and 9.4% growth in international business. EBITDA margin contracted 20 bps y-o-y to 19.2% as sharp GM contraction of 460 bps y-o-y (due to inflation in sugar prices and phasing of promotional spends by PepsiCo — this gets discounted from VBL’s concentrate pricing) was negated by a similar quantum of savings in other expenditure (led by GST-led savings and lower logistics costs due to realignment of operations). Recurring PAT growth was largely aided by a sharp 54 % y-o-y drop in interest costs. For 9MCY17, VBL reported 1%, 4% and 75% growth in revenue, EBITDA and PAT. EBITDA margin expanded 60 bps y-o-y to 23.1% and recurring EPS stood at Rs 15.5/share. Volumes for the period declined 1% y-o-y to 245 million cases.

Management highlighted – (1) after destocking impact in 2QCY17, it has witnessed partial recovery in 3QCY17 in India business, (2) its international operations continue to register robust growth – for 9MCY17 Nepal, Sri Lanka and Morocco registered 20%, 11.4% and 15% growth respectively, (3) it has completed acquisition of Odisha/MP territories from PepsiCo along with two facilities for Rs 1.3 billion and (4) it has rolled out energy drink Sting at competitive pricing.

Get latest news and updates on Auto Expo 2018, check breaking news on Budget 2018, like us on Facebook and follow us on Twitter.

  1. No Comments.

Go to Top